CoreCivic, Inc.CXW

CoreCivic’s most recent quarterly filing shows a company that collects $614.7m in revenue but generates just $13.8m in operating cash flow-a cash-to-revenue ratio that would make a small retail counter blush. The balance sheet lists $3.37bn in assets against $1.97bn in liabilities, leaving $1.40bn of shareholders’ equity that’s been drifting downward like a slow-moving barge in a canal. Diluted earnings per share clock in at 38 cents, which is roughly the cost of a prison phone call that lasts 38 seconds. The company’s own product pages promise ‘comprehensive and compassionate health care’ and ‘circadian design’ to brighten detention centres, but the numbers suggest the real product is occupancy contracts rather than healing environments (source: SEC EDGAR 10-Q ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1070985/000119312526120944/0001193125-26-000070.txt).

CoreCivic describes itself as a provider of ‘detention services’ that does not ‘enforce immigration laws’ or dictate deportation outcomes, yet its facilities house people whose immigration status is actively managed by government partners. The company’s marketing rails lean hard on ‘reducing recidivism’ and ‘compassionate care,’ while its 11-K filing quietly notes that the board’s 401(k) plan was amended in 2022 to allow in-service withdrawals-a feature typically marketed to companies expecting orderly retirements rather than headline risk. The ‘Setting the Record Straight’ page about Dilley insists CoreCivic is merely a contractor, not a policy actor, yet the company’s fortunes still rise and fall with government contracting cycles (source: CoreCivic product rail, https://www.corecivic.com/what-we-do-what-we-dont-do; SEC EDGAR 11-K filed 2026-06-26, https://www.sec.gov/Archives/edgar/data/1070985/000119312526284955/d46524d11k.htm).

The filing evidence shows $209.7m in cash and cash equivalents against $1.97bn in liabilities, a liquidity cushion that would look flimsy even if the company were allowed to run a small retail counter. Net cash provided by operating activities is a meagre $13.8m for the quarter, and diluted weighted average shares outstanding sit at 98.7m, up from 95.4m a year ago-suggesting dilution has been the funding instrument of choice rather than cash flow. The company’s health services division logged 804,500 onsite medical encounters in 2024, but the cash register isn’t exactly singing: the latest 10-Q shows operating cash flow that’s barely enough to cover the cost of a single facility lease for a weekend. The ‘Healing Light’ feature on circadian design is all very photogenic, but the balance sheet remains stubbornly unilluminated (source: SEC EDGAR 10-Q ending 2026-03-31; SEC EDGAR company facts JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0001070985.json).

The latest 8-K filings from July 6 and July 13 show routine disclosures about director appointments and equity awards, which is the corporate equivalent of rearranging deck chairs on a ship that’s already listed. The company’s ‘Comprehensive and Compassionate Health Care’ page features a stock image of a stethoscope on a clipboard, a visual cue that’s less ‘healthcare innovation’ and more ‘healthcare metaphor.’ Meanwhile, the ‘Setting the Record Straight’ page about Dilley is a masterclass in passive voice: CoreCivic doesn’t do deportations, it merely provides the infrastructure on which others act-like a knife manufacturer insisting it only sells blades, not cuts (source: SEC EDGAR 8-K filed 2026-07-06, https://www.sec.gov/Archives/edgar/data/1070985/000119312526295590/d110529d8k.htm; CoreCivic product rail, https://www.corecivic.com/news/setting-the-record-straight-dilley-immigration-processing-center).

If CoreCivic’s product rail is to be believed, the company’s facilities are ‘healing environments’ where ‘circadian design’ brings the outside in. The filing rail, however, tells a different story: a company whose equity base has shrunk, whose cash generation is anaemic, and whose primary revenue driver remains tethered to government contracting cycles it can’t control. The 2024 tally of 804,500 onsite medical encounters sounds impressive until you recall that each encounter is billed to a government partner at rates that don’t cover the company’s cost of capital. The ‘Healing Light’ imagery is a fine touch, but the balance sheet is still running on fumes (source: CoreCivic product rail, https://www.corecivic.com/news/a-healing-light-how-circadian-design-brings-the-outside-in; SEC EDGAR company facts JSON).

CoreCivic’s latest SEC submissions JSON lists routine director elections and equity awards, which is the corporate equivalent of updating the company’s LinkedIn banner without changing the underlying business. The company’s product pages promise ‘compassionate care’ and ‘reducing recidivism,’ but the filings reveal a company whose cash generation is so weak that $13.8m in operating cash flow for the quarter barely covers the interest on its liabilities. The ‘Comprehensive and Compassionate Health Care’ page features a stock image of a stethoscope draped over a clipboard-a visual cue that’s less ‘innovation’ and more ‘stock image theatre.’ The balance sheet, meanwhile, is the real production: $3.37bn in assets against $1.97bn in liabilities, leaving a shareholders’ equity base that’s been eroding like a prison wall in a rainstorm (source: SEC EDGAR submissions JSON, https://data.sec.gov/submissions/CIK0001070985.json).